niacinamide has been researched along with Leukoencephalopathy Syndrome, Posterior in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 10-year-old boy with FLT3-ITD-positive acute myelogenous leukemia who developed PRES during sorafenib treatment has been presented here." | 3.83 | Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia. ( Bayhan, T; Cetin, M; Gumruk, F; Isgandarova, F; Kuskonmaz, B; Tavil, B; Unal, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tavil, B | 1 |
| Isgandarova, F | 1 |
| Bayhan, T | 1 |
| Unal, S | 1 |
| Kuskonmaz, B | 1 |
| Gumruk, F | 1 |
| Cetin, M | 1 |
| Dogan, E | 1 |
| Aksoy, S | 1 |
| Arslan, C | 1 |
| Dede, DS | 1 |
| Altundag, K | 1 |
2 other studies available for niacinamide and Leukoencephalopathy Syndrome, Posterior
| Article | Year |
|---|---|
Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia.
Topics: Antineoplastic Agents; Child; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Ne | 2016 |
Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; | 2010 |